These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38301948)
1. Lower complement C1q levels in first-episode psychosis and in schizophrenia. Koskuvi M; Malwade S; Gracias Lekander J; Hörbeck E; Bruno S; Holmen Larsson J; Pelanis A; Isgren A; Goulding A; Fatouros-Bergman H; Samudyata ; Schalling M; Piehl F; Erhardt S; Landen M; Cervenka S; Orhan F; Sellgren CM Brain Behav Immun; 2024 Mar; 117():313-319. PubMed ID: 38301948 [TBL] [Abstract][Full Text] [Related]
2. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Hatzimanolis A; Foteli S; Stefanatou P; Ntigrintaki AA; Ralli I; Kollias K; Nikolaou C; Gazouli M; Stefanis NC Eur Arch Psychiatry Clin Neurosci; 2022 Oct; 272(7):1219-1228. PubMed ID: 35532796 [TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia. Gracias J; Orhan F; Hörbeck E; Holmén-Larsson J; Khanlarkani N; Malwade S; Goparaju SK; Schwieler L; Demirel İŞ; Fu T; Fatourus-Bergman H; Pelanis A; Goold CP; Goulding A; Annerbrink K; Isgren A; Sparding T; Schalling M; Yañez VAC; Göpfert JC; Nilsson J; Brinkmalm A; Blennow K; Zetterberg H; Engberg G; Piehl F; Sheridan SD; Perlis RH; Cervenka S; Erhardt S; Landen M; Sellgren CM Nat Commun; 2022 Nov; 13(1):6427. PubMed ID: 36329007 [TBL] [Abstract][Full Text] [Related]
4. Complement proteins are elevated in blood serum but not CSF in clinical high-risk and antipsychotic-naïve first-episode psychosis. Cropley VL; Kittel M; Heurich M; Föcking M; Leweke FM; Pantelis C Brain Behav Immun; 2023 Oct; 113():136-144. PubMed ID: 37437819 [TBL] [Abstract][Full Text] [Related]
5. Investigation of peripheral complement factors across stages of psychosis. Laskaris L; Zalesky A; Weickert CS; Di Biase MA; Chana G; Baune BT; Bousman C; Nelson B; McGorry P; Everall I; Pantelis C; Cropley V Schizophr Res; 2019 Feb; 204():30-37. PubMed ID: 30527272 [TBL] [Abstract][Full Text] [Related]
6. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. Fonseca MI; Chu SH; Hernandez MX; Fang MJ; Modarresi L; Selvan P; MacGregor GR; Tenner AJ J Neuroinflammation; 2017 Mar; 14(1):48. PubMed ID: 28264694 [TBL] [Abstract][Full Text] [Related]
7. Altered expression of microglial markers of phagocytosis in schizophrenia. Jenkins AK; Lewis DA; Volk DW Schizophr Res; 2023 Jan; 251():22-29. PubMed ID: 36527956 [TBL] [Abstract][Full Text] [Related]
8. The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis. Liu CM; Liu CC; Hsieh MH; Hwang TJ; Lin YT; Chien YL; Hwu HG Psychiatry Res; 2022 Oct; 316():114775. PubMed ID: 35985087 [TBL] [Abstract][Full Text] [Related]
9. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q. Hammond JW; Qiu WQ; Marker DF; Chamberlain JM; Greaves-Tunnell W; Bellizzi MJ; Lu SM; Gelbard HA Glia; 2018 Dec; 66(12):2563-2574. PubMed ID: 30325063 [TBL] [Abstract][Full Text] [Related]
10. Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration. Jiao H; Rutar M; Fernando N; Yednock T; Sankaranarayanan S; Aggio-Bruce R; Provis J; Natoli R Mol Neurodegener; 2018 Aug; 13(1):45. PubMed ID: 30126455 [TBL] [Abstract][Full Text] [Related]
11. CSF dopamine is elevated in first-episode psychosis and associates to symptom severity and cognitive performance. Orhan F; Goiny M; Becklén M; Mathé L; Piehl F; Schwieler L; Fatouros-Bergman H; Farde L; Cervenka S; Sellgren CM; Engberg G; Erhardt S Schizophr Res; 2023 Jul; 257():34-40. PubMed ID: 37271040 [TBL] [Abstract][Full Text] [Related]
12. CSF GABA is reduced in first-episode psychosis and associates to symptom severity. Orhan F; Fatouros-Bergman H; Goiny M; Malmqvist A; Piehl F; ; Cervenka S; Collste K; Victorsson P; Sellgren CM; Flyckt L; Erhardt S; Engberg G Mol Psychiatry; 2018 May; 23(5):1244-1250. PubMed ID: 28289277 [TBL] [Abstract][Full Text] [Related]
13. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia. Purves-Tyson TD; Robinson K; Brown AM; Boerrigter D; Cai HQ; Weissleder C; Owens SJ; Rothmond DA; Shannon Weickert C Front Immunol; 2020; 11():2002. PubMed ID: 33133060 [TBL] [Abstract][Full Text] [Related]
14. Complement factors in newly diagnosed Nigerian schizoprenic patients and those on antipsychotic therapy. Idonije OB; Akinlade KS; Ihenyen O; Arinola OG Niger J Physiol Sci; 2012 Jun; 27(1):19-21. PubMed ID: 23235303 [TBL] [Abstract][Full Text] [Related]
15. Complement component C4 levels in the cerebrospinal fluid and plasma of patients with schizophrenia. Gallego JA; Blanco EA; Morell C; Lencz T; Malhotra AK Neuropsychopharmacology; 2021 May; 46(6):1140-1144. PubMed ID: 32961544 [TBL] [Abstract][Full Text] [Related]
16. Dissecting the impact of complement component 4A in bipolar disorder. Hörbeck E; Jonsson L; Malwade S; Karlsson R; Pålsson E; Sigström R; Sellgren CM; Landén M Brain Behav Immun; 2024 Feb; 116():150-159. PubMed ID: 38070620 [TBL] [Abstract][Full Text] [Related]
17. Salivary cortisol in early psychosis: New findings and meta-analysis. Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686 [TBL] [Abstract][Full Text] [Related]